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Over the past two decades, there has been a tremendous
interestintheapplicationoftissueengineeringprotocolsand
stem cells, particularly, mesenchymal stem cells (MSCs) to
develop cell-based strategies for regeneration, replacement,
or repair of damaged tissues. The 1990s brought the advent
of tissue engineering, where MSCs were diﬀerentiated in
the presence of speciﬁc bioactive molecules towards bone,
cartilage and other musculoskeletal tissues. The beginning
of the 21st century saw the emergence of cell-based clinical
therapies using MSCs at three diﬀerent approaches. Firstly,
tissue-engineering approaches in which MSCs are seeded
into three-dimensional (3-D) scaﬀolds in order to gener-
ate functional tissues for replacement of defective tissues.
Secondly, we see the use of MSC transplantation to replace
defective host cells and thirdly, harnessing the properties of
MSCstoactascytokine/growthfactorproducerstostimulate
repair or inhibit degenerative processes.
Reﬂecting the enormous interest of both our readership
and authors in this promising ﬁeld, we are pleased to
present this special issue. This special issue presents a total
of 21 paper including research papers and comprehensive
reviewsthataimtoprovideabetterunderstandingofcurrent
basic research ﬁndings, clinical data, and the challenges
encountered on the application of biologicals (cytokines/
growth factors), tissue engineering, and stem cells in the
treatment of musculoskeletal lesions aﬀecting bone, carti-
lage, intervertebral discs, ligaments, menisci, muscle, and
tendons.
The treatment of large bone defects remains a major
challenge for orthopaedic reconstructive surgeons. Gener-
ation of bone grafts with osteoconductive, osteoinductive,
and osteogenic properties via tissue engineering strategies
may resolve this problem. W. Khan et al. review available
literature on bone tissue engineering to understand its prin-
ciple, current limitations, and clinical relevance in bone
reconstructive surgery.
Hyaline cartilage is an avascular tissue covering the end
of long bones in diarthrodial joints where it fosters near
frictionless movement and load bearing. Current treatment
options for damaged hyaline cartilage lead to the forma-
tion of ﬁbrocartilage tissue that neither recapitulates the
molecular phenotype nor the biomechanical properties of
hyaline cartilage. While MSCs have the capacity to be diﬀer-
entiated into cartilage cells: chondrocytes, current methods
of chondrogenic induction of MSCs result in ﬁbrocartilage
formation and expression of templates for osteogenesis. In
this special issue, U. Longo et al. provide a comprehensive
review of available literature on the role of gene therapy and
MSCs to develop therapeutic strategies for hyaline cartilage
regeneration.
Low back pain is one of the largest health problems
in the Western world today aﬀecting 8 in 10 of the adult
population at some point in their lives and has an enor-
mous impact on Western economies due to occupational
incapacities and healthcare cost. While the causes of low-
back pain are thought to be multifactorial, the degeneration
of intervertebral discs (IVD) is frequently seen in almost
all cases. U. Longo et al. provide two review papers on
the prevention and management of IVD degeneration. One
paper focused on the role of biologics: growth factors and2 Stem Cells International
anticatabolic agents, to stimulate synthesis of extracellular
matrix molecules that are central to IVD functionality and
inhibition of the enzymes responsible for IVD degradation.
The other paper provided a review of in vitro and in vivo
evidence on the potential application of MSCs to treat IVD
degeneration.
Ligaments possess the remarkable capacity to connect
two or more bones, stabilize joints, and to sustain excessive
mechanical loads. However, they have a limited reparative
and regenerative capacity. Current treatment modalities,
that comprise the use of autografts and allografts, suﬀer
from a variety of issues that include donor site morbidity,
pain,alteredharvestbiomechanics,anddiseasetransmission.
Hence there is a need for new treatments. Tissue engineering
strategies have been advocated as a potential approach
to resolve these problems. Calgor Yilgor et al. provide
a review paper summarizing the application of biologics,
cells (MSCs and ﬁbroblast) scaﬀolds and bioreactors in
ligament regeneration. While in a paper, W. Yates et al.
focused their review of current literature on the relevance
of ligament tissue engineering on anterior cruciate ligament
reconstruction. S. Rathbone et al. report that most British
orthopaedic surgeons will use tissue-engineered anterior
cruciate ligament in clinical practice.
The meniscus is a vital tissue for normal healthy knee
joint biomechanics. Meniscus injury is a major risk factor for
the development of osteoarthritis. Unfortunately, the repar-
ative capacity of the meniscus is limited to its vascularized
region. In a research article, D. Ferris et al. used equine
autologous bone marrow stromal mesenchymal stem cell
and ﬁbrin glue to demonstrate healing of lacerated equine
menisci in a nude mice model. Their study may serve as
a promising model system to study cell-based therapies for
meniscus repair. In their paper, U. Longo et al. produced a
review of available literature on current strategies of tissue
engineering for the management of meniscal defects. In
another paper, U. Longo et al. focused their review on
proposed biological strategies directed to enhance meniscus
repair in the avascular region.
Despite the fact that skeletal muscle has the capacity to
repair and regenerate, muscle function is compromised due
ﬁbrotic scar tissue formation after injury. U. Longo et al.
review current literature on the application of biologicals,
such as platelet rich plasma and tissue engineering strategies
comprising scaﬀolds and MSCs in the management of
skeletal muscle injuries. While S. MacLean et al. discuss
current literature on diﬀerent stem cell types, gene therapy,
and tissue engineering approaches that may be applicable to
skeletal muscle regeneration following injury and muscular
dystrophy.
Tendons are central to normal functionality of the mus-
culoskeletal system where they connect muscle and bone
to produce joint movement. Unfortunately, the reparative
and regenerative capacities of tendons are limited because
of their low cellularity. Tendon injuries are a common cause
of morbidity in the population and account for a signiﬁcant
health care burden. Preclinical studies with a variety of cell
types including MSCs, tendocytes, dermal ﬁbroblast, have
beenevaluatedfortendonrepairorregeneration.Whilethese
studiesshowpromiseofcell-basedoptionsintreatingtendon
disorder, there have been little clinical applications. U. Young
reviews the application of stem cells in tendon disorders. L.
Gulottaetal.reviewcurrentliteratureontheuseofstemcells
with or without growth factors to enhance tendon repair.
S. Maclean et al. review stem cell-based tissue engineering
strategies in the management of tendon injuries. In a clinical
study, C. Pascual-Garrido et al. report a 5-year follow up
clinical improvement in a small cohort of patients with
chronic patellar tendinopathy after treatment with untreated
bone marrow stromal stem cells. N. Maﬀulli et al. discuss
current literature on tissue engineering approaches to treat
rotator cuﬀ tears. While U. Longo et al. review current
literature on available biological and synthetic scaﬀolds for
tendon tissue engineering.
The study of stem cells isolated from a variety of tissues
often oﬀers unique insights into similarities or diﬀerences
in diﬀerentiation potential between stem cell populations.
Schmitt and coauthors discuss current literature on diﬀerent
stem cells use in orthopaedic regenerative medicine. While
in a research paper, Marmotti and colleagues report a novel
method of isolating stem cells from umbilical cord for
orthopaedic tissue engineering. Furthermore, they showed
evidence that the stem cells had the capacity to undergo
myogenesis, adipogenesis, chondrogenesis, and osteogenesis.
E. Fossett and W. Khan discuss in a review how MSCs
seeding density, age, and gender of MSCs donor aﬀect the
proliferative capacity of MSCs.
Insummary,weareveryexcitedtopresenttoourreaders
this special collection of outstanding review and research
articles and would like to take this opportunity to thank all
our authors for their contributions and support to Stem Cells
International.
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